Evidence map›Paper›PMID 31901446›Full record

ArticleMolecular cell2020

Su(var)2-10 and the SUMO Pathway Link piRNA-Guided Target Recognition to Chromatin Silencing.

Maria Ninova, Yung-Chia Ariel Chen, Baira Godneeva, Alicia K Rogers, Yicheng Luo, Katalin Fejes Tóth, Alexei A Aravin

Abstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. In thebioRxiv : the preprint server for biology · 2026
    Article
  5. piRNA direct the chromatin reader to its genomic targets.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. H3K27me3 expands the epigenetic control of piRNA transcription.Nature structural & molecular biology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. H3K14ac facilitates the reinstallation of constitutive heterochromatin inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. piRNA associates with immune diseases.Cell communication and signaling : CCS · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. The Ancient Origin and Function of Germline Cysts.Results and problems in cell differentiation · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria NinovaCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA.
Yung-Chia Ariel ChenCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA.
Baira GodneevaCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA; Institute of Molecular Genetics, Russian Academy of Sciences, Moscow 123182, Russia.
Alicia K RogersCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA.
Yicheng LuoCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA.
Katalin Fejes TóthCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA. Electronic address: kft@caltech.edu.
Alexei A AravinCalifornia Institute of Technology, Division of Biology and Biological Engineering, 147-75, Pasadena, CA 91125, USA. Electronic address: aaa@caltech.edu.

Funding

Molecular Mechanism of the piRNA BiogenesisR01GM097363 · NIGMS · CORNELL UNIVERSITY · PI ARAVIN, ALEXEI A. · 2011 to 2025
$4.0M
Understanding the mechanism of Piwi-induced transcriptional silencingR01GM110217 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI FEJES TOTH, KATALIN · 2014 to 2024
$3.1M
Elucidating the role of SUMO ligase Su(var)2-10 in piRNA-guided transcriptional silencing and repressive chromatin formationK99HD099316 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI NINOVA, MARIA ANTONINOVA · 2019 to 2020
$259k
NICHD NIH HHS K99 HD099316NIGMS NIH HHS R01 GM097363NIGMS NIH HHS R01 GM110217
6 · The paper itself

Abstract

Regulation of transcription is the main mechanism responsible for precise control of gene expression. Whereas the majority of transcriptional regulation is mediated by DNA-binding transcription factors that bind to regulatory gene regions, an elegant alternative strategy employs small RNA guides, Piwi-interacting RNAs (piRNAs) to identify targets of transcriptional repression. Here, we show that in Drosophila the small ubiquitin-like protein SUMO and the SUMO E3 ligase Su(var)2-10 are required for piRNA-guided deposition of repressive chromatin marks and transcriptional silencing of piRNA targets. Su(var)2-10 links the piRNA-guided target recognition complex to the silencing effector by binding the piRNA/Piwi complex and inducing SUMO-dependent recruitment of the SetDB1/Wde histone methyltransferase effector. We propose that in Drosophila, the nuclear piRNA pathway has co-opted a conserved mechanism of SUMO-dependent recruitment of the SetDB1/Wde chromatin modifier to confer repression of genomic parasites.

Indexed as

AnimalsArgonaute ProteinsCell NucleusChromatinDNA Transposable ElementsDrosophila melanogasterDrosophila ProteinsGene Expression RegulationGene SilencingProtein BindingProtein Inhibitors of Activated STATRNA, Small InterferingSmall Ubiquitin-Related Modifier ProteinsTranscription, GeneticArgonaute ProteinsChromatinDNA Transposable ElementsDrosophila ProteinsProtein Inhibitors of Activated STATRNA, Small InterferingSmall Ubiquitin-Related Modifier ProteinsSu(var)2-10 protein, DrosophilachromatinheterochromatinpiRNAsilencingSUMOSu(var)2-10transposon

Identifiers

PMID31901446
PMCPMC7007863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.